Table 1: Demographics and disease characteristics at diagnosis (N = 60).
|
Variable |
|
|
|
Gender, n (%)
|
Males |
34 (56.7) |
|
Females |
26 (43.3) |
|
|
Nationality, n (%) |
Algerian |
60 (100.0) |
|
Race, n (%)
|
Caucasian |
38 (64.4) |
|
Black |
18 (30.5) |
|
|
North Africa: Arabic |
3 (5.1%) |
|
|
missing |
1 |
|
|
Age at diagnosis
|
Mean (SD) |
55.1 (13.7) |
|
Median |
54.9 |
|
|
Minimum; Maximum |
21.2; 82.1 |
|
|
PTCL Type, n (%)
|
Cutaneous |
9 (15.0) |
|
Extranodal |
8 (13.3) |
|
|
Nodal |
27 (45.0) |
|
|
Leukemic |
13 (21.7) |
|
|
Lymphoblastic T lymphoma |
2 (3.4) |
|
|
missing |
1 (1.7) |
|
|
Disease stage at diagnosis, n (%)
|
1 |
4 (6.8) |
|
2 |
7 (11.9) |
|
|
3 |
10 (16.9) |
|
|
4 |
38 (64.4) |
|
|
missing |
1 |
|
|
ECOG performance status at diagnosis, n (%)
|
0 |
16 (28.1) |
|
1 |
16 (28.1) |
|
|
2 |
19 (33.3) |
|
|
3 |
4 (7.0) |
|
|
4 |
2 (3.5) |
|
|
missing |
3 |
|
SD: Standard Deviation; ECOG: Eastern Cooperative Oncology Group